Terns Pharmaceuticals raised $80M Series B venture round, led by Carl Gordon.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
Vivo CapitalLEAD | Venture Capital | — |
OrbiMedLEAD | Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$167M
Top Valuation
-
Terns Pharmaceuticals raised $80M in a Series B round.
The round was announced on 10/30/18.
The round was led by Carl Gordon, Vivo Capital.